Completed PHASE1 INTERVENTIONAL 1-arm NCT00185848

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.

Sponsor: Sanjiv Sam Gambhir

Conditions Arthritis, Rheumatoid Brain Cancer Central Nervous System Neoplasms Glioma

Interventions [18F]FHBG

Updated 8 times since 2017 Last updated: Mar 12, 2017 Started: Apr 30, 2005 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Arthritis, Rheumatoid and Brain Cancer, this trial is completed. The trial is conducted by Sanjiv Sam Gambhir and has accumulated 8 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE1
Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Apr 2017 — Jun 2018 [monthly]

Completed PHASE1

Phase: PHASE2 → PHASE1
Feb 2017 — Apr 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanjiv Sam Gambhir

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States
• Stanford, United States